| 1 |
33535038 | An IDH1-vitamin C crosstalk drives human erythroid development by inhibiting pro-oxidant mitochondrial metabolism. | 2021 Feb 2 |
2 |
| 2 |
33810170 | Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy? | 2021 Mar 22 |
2 |
| 3 |
31548295 | Blockade of Glutathione Metabolism in IDH1-Mutated Glioma. | 2020 Jan |
1 |
| 4 |
32312817 | Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism. | 2020 May 5 |
2 |
| 5 |
30639360 | Oxalomalate reduces tumor progression in melanoma via ROS-dependent proapoptotic and antiangiogenic effects. | 2019 Mar |
1 |
| 6 |
30720071 | Mutation of IDH1 aggravates the fatty acid‑induced oxidative stress in HCT116 cells by affecting the mitochondrial respiratory chain. | 2019 Apr |
1 |
| 7 |
31020875 | Oxalomalate suppresses metastatic melanoma through IDH-targeted stress response to ROS. | 2019 Apr |
4 |
| 8 |
31462501 | Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma. | 2019 Nov |
1 |
| 9 |
29448107 | Decrease in the cytosolic NADP+-dependent isocitrate dehydrogenase activity through porcine sperm capacitation. | 2018 Feb 26 |
3 |
| 10 |
29879375 | IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity. | 2018 Jun 7 |
4 |
| 11 |
28564604 | Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation. | 2017 May 30 |
2 |
| 12 |
28827794 | Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP+-dependent isocitrate dehydrogenase (IDH). | 2017 Aug |
1 |
| 13 |
27049945 | Reductive carboxylation supports redox homeostasis during anchorage-independent growth. | 2016 Apr 14 |
2 |
| 14 |
27810736 | Oxalomalate reduces expression and secretion of vascular endothelial growth factor in the retinal pigment epithelium and inhibits angiogenesis: Implications for age-related macular degeneration. | 2016 Dec |
2 |
| 15 |
25283382 | Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation. | 2015 Feb |
3 |
| 16 |
26363012 | Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198. | 2015 Nov 15 |
2 |
| 17 |
24362902 | An IDH1 mutation inhibits growth of glioma cells via GSH depletion and ROS generation. | 2014 Jun |
1 |
| 18 |
23115158 | Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. | 2013 Jan |
3 |
| 19 |
23541771 | NADP+ -dependent IDH1 R132 mutation and its relevance for glioma patient survival. | 2013 Jun |
1 |
| 20 |
19291592 | Glutathionylation regulates cytosolic NADP+-dependent isocitrate dehydrogenase activity. | 2009 Apr |
1 |